Consortium for Medical Marijuana Clinical Outcomes Research establishes leadership team and grants program
The inaugural Consortium for Medical Marijuana Clinical Outcomes board meeting was held on Aug. 19 in Gainesville.
The inaugural Consortium for Medical Marijuana Clinical Outcomes board meeting was held on Aug. 19 in Gainesville.
UF researchers reviewed more than 13 million patients using carisoprodol, a powerful muscle relaxant.
As the lead institution, UF will receive $1.5 million in annual recurrent funding from the state of Florida to support the research mission of the Consortium for Medical Marijuana Clinical Outcomes Research.
A new study by University of Florida Health researchers shows quinolone ear drops might cause a perforated eardrum, which can lead to hearing loss.
The Centers for Medicare and Medicaid Services criteria are used to flag high-risk patients for opioid abuse and overdose.
The center will unite researchers interested in using big data to evaluate drugs and the safety of medications in real-world populations.
The FDA awarded a $330,000 grant to Almut Winterstein, Ph.D., to lead the 18-month study.
The 2018 Pharmacy Practice Research Award was presented at the ASHP Midyear meeting in Anaheim.
As president-elect, Almut Winterstein will serve on the executive board and chair the strategic planning committee. She joined ISPE in 2000 and has held numerous leadership roles during the past two decades.
The researchers reviewed medical claims for around half million adults in 29 states who had used either azithromycin or amoxicillin during a 10 year period.